Cell No. : Cell Name RCB6076 : A80  update : 2025/03/12
Comment			Currently not ready.
Comment from the depositor			Rat hybridoma producing anti-human CXCR4 monoclonal antibodis（3 clones: A145 recognizing N -terminal region of the CXCR4; A120 recognizing a steric region of the CXCR4 consisting ECL1 and 2; and A80 recognizing a steric region of ECL3）
Terms and conditions
Remarks
Order Form
			Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
	Basic information	Expected time	Upon a request we will start preparation. Contact us: cellkitaku.brc@riken.jp
Reference information		Reference	1
		User's Publication	0

Top

Reference

22660  Tanaka R, Yoshida A, Murakami T, Baba E, Lichtenfeld J, Omori T, Kimura T, Tsurutani N, Fujii N, Wang ZX, Peiper SC, Yamamoto N, Tanaka Y.  Unique monoclonal antibody recognizing the third extracellular loop of CXCR4 induces lymphocyte agglutination and enhances human immunodeficiency virus type 1-mediated syncytium formation and productive infection.  J Virol.  2001  75(23):11534-11543.  PubMed ID: 11689635   DOI: 10.1128/JVI.75.23.11534-11543.2001

Top

User's Publication